SI-BONE, Inc. (FRA:2K3)

Market Cap	570.14M -21.8%
Revenue (ttm)	164.99M +23.3%
Net Income	-18.54M
EPS	-0.44
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	12.80
Previous Close	13.00
Day's Range	12.80 - 12.80
52-Week Range	10.60 - 17.90
Beta	n/a
RSI	37.12
Earnings Date	Feb 23, 2026

About SI-BONE

SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company offers proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products. It also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with a proprietary 3D-printed porous surface and fenestrated ...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2008
• Employees: 349
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2K3

Financial Performance

In 2024, SI-BONE's revenue was $167.18 million, an increase of 20.37% compared to the previous year's $138.89 million. Losses were -$30.91 million, -28.67% less than in 2023.

Financial numbers in USD